Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, Moye J Jr, Nugent R, Read J. Mofenson LM, et al. Among authors: pahwa s. J Infect Dis. 1997 May;175(5):1029-38. doi: 10.1086/516441. J Infect Dis. 1997. PMID: 9129063 Clinical Trial.
Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Read JS, Bethel J, Harris DR, Meyer WA 3rd, Korelitz J, Mofenson LM, Moye J Jr, Pahwa S, Rich K, Nugent RP. Read JS, et al. Among authors: pahwa s. Pediatr Infect Dis J. 1999 Feb;18(2):134-42. doi: 10.1097/00006454-199902000-00010. Pediatr Infect Dis J. 1999. PMID: 10048685
Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Harris DR, Rich K, Meyer WA 3rd, Read JS, Moye J Jr, Nugent RP, Korelitz J, Bethel J, Pahwa S. Mofenson LM, et al. Among authors: pahwa s. AIDS. 1999 Jan 14;13(1):31-9. doi: 10.1097/00002030-199901140-00005. AIDS. 1999. PMID: 10207542 Clinical Trial.
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.
Kovacs A, Montepiedra G, Carey V, Pahwa S, Weinberg A, Frenkel L, Capparelli E, Mofenson L, Smith E, McIntosh K, Burchett SK; Pediatric AIDS Clinical Trials Group 366 Study Team. Kovacs A, et al. Among authors: pahwa s. J Infect Dis. 2005 Jul 15;192(2):296-302. doi: 10.1086/430922. Epub 2005 Jun 14. J Infect Dis. 2005. PMID: 15962224 Clinical Trial.
Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, Kovacs A, Burchett SK; Pediatric AIDS Clinical Trials Group 366 Team. Weinberg A, et al. Among authors: pahwa s. Clin Infect Dis. 2004 Jul 1;39(1):107-14. doi: 10.1086/420931. Epub 2004 Jun 14. Clin Infect Dis. 2004. PMID: 15206061
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.
Winter HS, Oleske JM, Hughes MD, McKinney RE Jr, Elgie C, Powell C, Purdue L, Puga AM, Jimenez E, Scott GB, Cruz ML, Moye J Jr; Pediatric AIDS Clinical Trials Group Protocol 247 Study Team. Winter HS, et al. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):222-32. doi: 10.1097/MPG.0b013e3181928937. J Pediatr Gastroenterol Nutr. 2009. PMID: 19543114 Free PMC article. Clinical Trial.
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.
HIV Paediatric Prognostic Markers Collaborative Study; Boyd K, Dunn DT, Castro H, Gibb DM, Duong T, Aboulker JP, Bulterys M, Cortina-Borja M, Gabiano C, Galli L, Giaquinto C, Harris DR, HugheS M, McKinney R, Mofenson L, Moye J, Newell ML, Pahwa S, Palumbo P, Rudin C, Sharland M, Shearer W, Thompson B, Tookey P. HIV Paediatric Prognostic Markers Collaborative Study, et al. Among authors: pahwa s. AIDS. 2010 May 15;24(8):1213-7. doi: 10.1097/QAD.0b013e3283389f41. AIDS. 2010. PMID: 20386428
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.
Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team. Tassiopoulos K, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16. J Acquir Immune Defic Syndr. 2008. PMID: 18209684 Free PMC article.
500 results